K833276

Substantially Equivalent

DRUG STANDARDS

Applicant: Supelco, Inc.
Product code: DKB
Advisory panel: Clinical Toxicology
Date received: 1983-09-22
Decision date: 1984-01-01
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Mchenry, IL, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.